Related Experiment Videos
Are neostriatal dopamine receptors co-localized?
D J Surmeier1, A Reiner, M S Levine
1Dept of Anatomy and Neurobiology, College of Medicine, University of Tennessee, Memphis 38163.
Trends in Neurosciences
|August 1, 1993
Summary
Dopamine receptors D1 and D2 families are likely co-localized in most neostriatal neurons. This finding impacts understanding of dopaminergic signaling in Parkinson's disease and schizophrenia.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Dopamine's postsynaptic effects in the neostriatum are mediated by five G-protein-coupled receptors.
- The co-localization of these dopamine receptors within neostriatal neurons is a subject of ongoing scientific debate.
- This controversy has significant implications for therapeutic strategies targeting dopaminergic signaling disorders.
Purpose of the Study:
- To review and analyze molecular and cellular evidence regarding dopamine receptor co-localization in the neostriatum.
- To evaluate new data from single-cell mRNA amplification and patch-clamping techniques.
- To resolve the controversy surrounding dopamine receptor distribution in neostriatal neurons.
Main Methods:
- Review of existing molecular and cellular studies on dopamine receptor distribution.
- Analysis of data from single-cell mRNA amplification.
- Examination of patch-clamp recordings from isolated neostriatal neurons.
Main Results:
- Evidence largely supports the co-localization of dopamine receptor families D1 and D2.
- Co-localization is observed in the majority of neostriatal efferent neurons.
- New techniques provide critical data for assessing receptor distribution.
Conclusions:
- The findings suggest significant co-localization of functionally important D1 and D2 dopamine receptors.
- This co-localization has substantial implications for parallel processing models of the neostriatum.
- Understanding receptor distribution is crucial for developing effective treatments for Parkinson's disease and schizophrenia.